Skip to main navigation Skip to search Skip to main content

Pharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalClinical Drug Investigation
StatePublished - 2015.01.1

Cite this